code,company,date,text
AMGN,Amgen Inc,2019-04-18,Goldman Figures Out Best Times to Enter and Exit Earnings Trades
AMGN,Amgen Inc,2019-04-17,Amgen Falls 3%
AMGN,Amgen Inc,2019-04-16,Brainstorm Health: Workplace Wellness  Weight Loss Device  Amgen Bone Drug Price
AMGN,Amgen Inc,2019-04-16,Amgen prices Evenity at $1 825 per month
AMGN,Amgen Inc,2019-04-15,U.S. launch of Amgen's Evenity underway
AMGN,Amgen Inc,2019-04-10,Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug
AMGN,Amgen Inc,2019-04-10,The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster  PhaseBio Offering
AMGN,Amgen Inc,2019-04-09,Brainstorm Health: Best Places to Work  Measles Emergency  Amgen Osteoporosis Drug
AMGN,Amgen Inc,2019-04-09,FDA approves Amgen's Evenity for treatment of osteoporosis in postmenopausal women 
AMGN,Amgen Inc,2019-04-09,FDA OKs Amgen's osteoporosis med Avenity
AMGN,Amgen Inc,2014-07-30,S&P 500  Nasdaq end up as Fed in no rush to raise rates 
AMGN,Amgen Inc,2014-07-29,A mixed quarter for bets on U.S. stock volatility
AMGN,Amgen Inc,2014-07-22,Facebook Has the Worst 401(k): Bloomberg
AMGN,Amgen Inc,2014-04-23,U.S. stocks dip on soft new home sales; Dow slides 0.08% 
AMGN,Amgen Inc,2014-04-23,U.S. stocks open mixed to lower with data ahead; Dow Jones up 0.03%
AMGN,Amgen Inc,2014-04-23,U.S. futures edge lower ahead of data  earnings; Dow Jones down 0.06%
AMGN,Amgen Inc,2014-04-21,AstraZeneca Cancer Drugs Seen As Draw For Pfizer
AMGN,Amgen Inc,2013-07-05,U.S. stocks higher on upbeat employment data; Dow Jones up 0.47% 
AMGN,Amgen Inc,2013-07-03,U.S. stocks lower after U.S. employment data; Dow Jones down 0.13% 
AMGN,Amgen Inc,2013-07-03,U.S. futures lower on China PMI  U.S. data ahead; Dow Jones down 0.53% 
AMGN,Amgen Inc,2015-01-27,Amgen profit tops expectations on Enbrel sales  tax credit
AMGN,Amgen Inc,2015-01-15,Insight: Big Pharma faces up to new price pressure from aggressive insurers
AMGN,Amgen Inc,2014-12-23,Exclusive: Express Scripts presses for more drug savings with coverage list 
AMGN,Amgen Inc,2014-12-17,Leaked Sony emails show Loeb influence on studio execs
AMGN,Amgen Inc,2014-12-17,Exclusive: Amgen's new leukemia drug to carry $178 000 price tag
AMGN,Amgen Inc,2014-10-28,U.S. stocks rally on earnings; Dow up 1.12% 
AMGN,Amgen Inc,2014-10-28,Wall St. jumps 1 percent  S&P ends above key level
AMGN,Amgen Inc,2014-10-28,Pfizer beats sales and profit forecasts  mum on future deals
AMGN,Amgen Inc,2014-10-27,Amgen profit tops Wall Street expectations; raises 2014 outlook
AMGN,Amgen Inc,2014-09-01,Pricing is key for new heart drugs challenging cheap generics
AMGN,Amgen Inc,2015-04-27,Wall St. falls; European shares rise on optimism over Greece
AMGN,Amgen Inc,2015-04-27,Wall St. ends down as biotechs drop 4 percent
AMGN,Amgen Inc,2015-04-21,U.S. stocks mixed  as subpar earnings offset possible mega pharma merger
AMGN,Amgen Inc,2015-03-23,U.S. stocks slightly down  as dollar continues downward trend
AMGN,Amgen Inc,2015-03-23,Exclusive: Biogen shortens name  expands ambitions in Alzheimer's  ALS
AMGN,Amgen Inc,2015-03-16,Wall St. bounces as dollar drops  Fed worries ease
AMGN,Amgen Inc,2015-03-16,U.S. stocks higher at close of trade
AMGN,Amgen Inc,2015-03-16,U.S. stocks rise broadly  as euro slows rapid descent toward parity
AMGN,Amgen Inc,2015-03-13,Shares in cholesterol drug makers mixed ahead of cardiology conference
AMGN,Amgen Inc,2015-03-02,Fidelity cuts Google stake by nearly a third amid shift to cheaper searches
AMGN,Amgen Inc,2015-07-30,Wall Street ends flat; Expedia flies after the bell
AMGN,Amgen Inc,2015-07-30,Amgen profit tops Street view  boosts full-year forecast
AMGN,Amgen Inc,2015-07-30,U.S. pre-market top movers of the day - Facebook  Whole Foods
AMGN,Amgen Inc,2015-07-30,4 Things to Watch This Morning
AMGN,Amgen Inc,2015-07-27,U.S. stocks fall for fifth straight session  as China sell-off weighs
AMGN,Amgen Inc,2015-07-27,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.73%
AMGN,Amgen Inc,2015-07-27,Teva to buy Allergan generic business for $40.5 billion  drops Mylan bid
AMGN,Amgen Inc,2015-05-26,AstraZeneca hit after psoriasis drug linked to suicide fears
AMGN,Amgen Inc,2015-05-26,Fight over hot new cholesterol drugs may be won in milligrams
AMGN,Amgen Inc,2015-05-13,How DNA sequencing is transforming the hunt for new drugs
AMGN,Amgen Inc,2015-12-15,European stocks open sharply higher  eyes on Fed; Dax up 1.69%
AMGN,Amgen Inc,2015-12-10,Special Report: Buybacks enrich the bosses even when business sags
AMGN,Amgen Inc,2015-11-10,Will 'Virtual Biotechs' Make Drugs Cheaper?
AMGN,Amgen Inc,2015-11-06,After big spending and hard lobbying  Pfizer eyes new tax home
AMGN,Amgen Inc,2015-10-07,S&P 500 reaches three-week high as health stocks rally
AMGN,Amgen Inc,2015-10-02,Novartis biosimilar copycat takes aim at Amgen's drug Enbrel
AMGN,Amgen Inc,2015-09-29,U.S. biotech bloodbath hits hedge funds but some bargains emerge
AMGN,Amgen Inc,2015-09-21,U.S. stocks rally  as investors continue to react to Fed decision
AMGN,Amgen Inc,2015-09-02,European stocks open higher  recover from heavy losses; Dax up 0.79%
AMGN,Amgen Inc,2015-09-01,Valeant gets right to develop AstraZeneca's psoriasis drug
AMGN,Amgen Inc,2016-07-06,Western Digital shares jump 4% amid CFO transition  increased outlook
AMGN,Amgen Inc,2016-05-25,Exclusive: Sanofi to unveil challenge to Medivation's board - sources
AMGN,Amgen Inc,2016-05-16,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
AMGN,Amgen Inc,2016-05-13,Dan Loeb's Third Point adds 700 000 shares of Alphabet: filing
AMGN,Amgen Inc,2016-05-10,Exclusive: Medivation succumbs to pressure to explore sale - sources
AMGN,Amgen Inc,2016-03-09,Another up day for oil helps Wall Street extend its rally
AMGN,Amgen Inc,2016-01-28,Top 5 Things to Know In the Market on Thursday
AMGN,Amgen Inc,2016-01-28,Wall Street points to higher open ahead of busy earnings day
AMGN,Amgen Inc,2016-01-14,U.S. stocks surge amid oil rally  dovish Fed comments on next rate hike
AMGN,Amgen Inc,2015-12-15,Amgen increases quarterly dividend by 27% for first quarter of 2016
AMGN,Amgen Inc,2016-11-09,California drug pricing initiative headed for defeat
AMGN,Amgen Inc,2016-11-01,Pfizer scraps cholesterol fighter  trims profit forecast
AMGN,Amgen Inc,2016-10-28,Wall St. rises amid robust GDP data  mixed earnings
AMGN,Amgen Inc,2016-10-27,Amgen Q3 top line up 2%; EPS up 10%; earnings guidance raised; shares ease 1% after hours
AMGN,Amgen Inc,2016-10-23,Berkshire Partners nears deal to acquire Masergy: sources
AMGN,Amgen Inc,2016-10-17,Pfizer set to start shipping Remicade biosimilar next month
AMGN,Amgen Inc,2016-10-02,Big Pharma vs Big Pharma in court battles over biosimilar drugs
AMGN,Amgen Inc,2016-09-22,UnitedHealth trims drug coverage  including Sanofi insulin
AMGN,Amgen Inc,2016-08-25,Stock futures lower as countdown to Yellen speech begins
AMGN,Amgen Inc,2016-08-12,Loeb's Third Point makes more new bets on energy  cuts stake in Dow
AMGN,Amgen Inc,2016-12-06,Trump's corporate tax holiday could spur pharma M&A
AMGN,Amgen Inc,2016-11-18,Wall Street slips  led by healthcare decline
AMGN,Amgen Inc,2016-11-16,Amgen's erenumab successful in second late-stage migraine study; shares up 1% after hours
AMGN,Amgen Inc,2016-11-16,Amgen's migraine drug succeeds in late-stage trial
AMGN,Amgen Inc,2016-11-15,Amgen submits BLA in U.S. for Avastin biosimilar
AMGN,Amgen Inc,2016-11-13,Late-stage study shows Amgen and UCB's romosozumab significantly increases bone mineral density in men with osteoporosis
AMGN,Amgen Inc,2016-11-13,Amgen's Parsabiv OK'd in Europe
AMGN,Amgen Inc,2016-11-12,J&J arthritis drug has mixed results against incumbents
AMGN,Amgen Inc,2016-11-10,Amgen and Janssen team up assessing drug combo in multiple myeloma
AMGN,Amgen Inc,2016-11-09,Biotechs love Trump  many ahead premarket
AMGN,Amgen Inc,2017-03-08,'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks
AMGN,Amgen Inc,2017-02-15,Pharma industry shuns Trump push for radical shift at FDA
AMGN,Amgen Inc,2017-02-02,Wall St. edges up on gains in consumer stocks
AMGN,Amgen Inc,2017-01-31,Trump pushes drugmakers for lower prices  more U.S. production
AMGN,Amgen Inc,2017-01-27,AbbVie's revenue misses as Hepatitis C  cancer drugs drag
AMGN,Amgen Inc,2017-01-18,Trump health pick defends stocks  says Americans won't lose insurance
AMGN,Amgen Inc,2017-01-18,Europe's oncologists back biosimilar versions of cancer drugs
AMGN,Amgen Inc,2017-01-06,Dow comes within 1 point of 20 000; indexes at records
AMGN,Amgen Inc,2016-12-06,Trump corporate tax plans may spur U.S. drug maker M&As 
AMGN,Amgen Inc,2016-12-06,Exclusive: Novartis in talks to sell some central nervous system drugs - sources
AMGN,Amgen Inc,2017-04-28,CytRx prices stock offering at $0.50; shares slump 19% premarket
AMGN,Amgen Inc,2017-04-26,Cost controls help offset lower Amgen first-quarter drug sales
AMGN,Amgen Inc,2017-04-26,Top 5 Things to Know In the Market on Wednesday
AMGN,Amgen Inc,2017-04-25,Notable earnings after Wednesday’s close
AMGN,Amgen Inc,2017-04-25,Money flow surges in biotechs  Novartis aims for more early-stage deals
AMGN,Amgen Inc,2017-04-24,Wolfe Research names favorite large-cap longs and shorts
AMGN,Amgen Inc,2017-04-05,Premarket analyst action - healthcare
AMGN,Amgen Inc,2017-03-17,U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10%
AMGN,Amgen Inc,2017-03-17,U.S. stocks close lower: Dow positive for the week 
AMGN,Amgen Inc,2017-03-17,Wall Street flat as tech gains offset weakness in banks
AMGN,Amgen Inc,2017-06-21,FDA aims at removing barriers to generic drug competition
AMGN,Amgen Inc,2017-06-15,Healthcare stocks can't fight the tide of selling
AMGN,Amgen Inc,2017-06-12,Wall St. falls as Apple drags tech shares lower
AMGN,Amgen Inc,2017-06-05,Amgen submits applications in U.S. and Europe to add CVOT data to Repatha label
AMGN,Amgen Inc,2017-06-02,Biotechs break through recent downtrend; IBB up 1%
AMGN,Amgen Inc,2017-05-31,Prescription trends for Synergy's Trulance ahead of projections  shares ahead 2% premarket
AMGN,Amgen Inc,2017-05-17,Healthcare firms fail to swim against the tide; all groups down
AMGN,Amgen Inc,2017-05-16,Majka takes yellow jersey after winning stage 2 in California
AMGN,Amgen Inc,2017-05-15,Galmed beats by $0.12  beats on revenue
AMGN,Amgen Inc,2017-05-02,Temasek  Yunfeng lead $75 million funding into China genomics firm
AMGN,Amgen Inc,2017-09-08,VanEck Vectors Morningstar Wide Moat ETF (MOAT) August Summary
AMGN,Amgen Inc,2017-09-07,AstraZeneca's tezepelumab shows significant treatment benefit in mid-stage asthma study; shares up 1% premarket
AMGN,Amgen Inc,2017-08-31,Biotechs lead the charge  IBB up 2.7%
AMGN,Amgen Inc,2017-08-30,FDA accepts Amgen's application to include survival data in Kyprolis label
AMGN,Amgen Inc,2017-08-28,Biotechs up in early trading
AMGN,Amgen Inc,2017-08-22,Biotechs in the mix on market's rally
AMGN,Amgen Inc,2017-07-28,AbbVie's profit beats on Humira  Imbruvica demand
AMGN,Amgen Inc,2017-07-27,TESARO out-licenses niraparib to Takeda for up to $340M
AMGN,Amgen Inc,2017-07-25,CryoPort inks deal with Novartis for logistics support of CAR-Ts; shares ahead 7% premarket
AMGN,Amgen Inc,2017-07-24,Notable earnings after Tuesday’s close
AMGN,Amgen Inc,2017-07-18,Canaccord defends Radius Health after FDA rejection of Amgen's romosozumab application
AMGN,Amgen Inc,2017-07-17,FDA rejects Amgen's marketing application for osteoporosis candidate romosozumab; resubmission to include ARCH and BRIDGE data
AMGN,Amgen Inc,2017-07-15,Stocks to watch next week
AMGN,Amgen Inc,2017-07-14,Amgen submits regulatory filings to add OS data to Kyprolis label
AMGN,Amgen Inc,2017-07-13,FDA Ad Com backs Amgen's ABP 215 in unanimous vote
AMGN,Amgen Inc,2017-07-08,Stocks to watch next week
AMGN,Amgen Inc,2017-06-23,European Ad Com backs pediatric formulation of Amgen's Mimpara
AMGN,Amgen Inc,2017-06-22,FDA rejects Pfizer's marketing application for Epogen biosimilar
AMGN,Amgen Inc,2017-06-21,Biotechs blaze as Trump draft order on drug prices would ease regulations
AMGN,Amgen Inc,2017-06-21,Biotechs ripping  IBB up almost 8% in three days
AMGN,Amgen Inc,2017-10-04,Premarket Gainers as of 9:05 am
AMGN,Amgen Inc,2017-10-03,VanEck Vectors Morningstar Wide Moat ETF (MOAT) September Summary
AMGN,Amgen Inc,2017-10-02,Med stocks up early  biotechs lead
AMGN,Amgen Inc,2017-09-28,FDA launches new tool aimed at easier access to adverse event data
AMGN,Amgen Inc,2017-09-28,Wall St. edges up on healthcare  tax plan hopes
AMGN,Amgen Inc,2017-09-28,Stocks – Wall Street Trades Mixed Despite Upward GDP Revision
AMGN,Amgen Inc,2017-09-26,Amgen teams up with Simcere to commercialize four biosimilars in China
AMGN,Amgen Inc,2017-09-24,Puerto Rico's fragile economy dealt new blow by Maria
AMGN,Amgen Inc,2017-09-22,Roche's Actemra/RoActemra OK'd in Europe for giant cell arteritis
AMGN,Amgen Inc,2017-09-21,"FDA's Woodcock says clinical trials system ""broken"""
AMGN,Amgen Inc,2017-10-24,Amgen declares $1.15 dividend
AMGN,Amgen Inc,2017-10-24,Big pharma/biotech players under pressure  Valeant only bright spot
AMGN,Amgen Inc,2017-10-21,Stocks to watch next week
AMGN,Amgen Inc,2017-10-20,Celgene selloff weighs on biotechs  IBB down 1%
AMGN,Amgen Inc,2017-10-16,Amgen teams up with Boston Children's Hospital to identify new pain targets
AMGN,Amgen Inc,2017-10-16,"President Trump at it again with comments on ""out of control"" drug prices"
AMGN,Amgen Inc,2017-10-11,Protagonist readies equity offering; shares up 1% after hours
AMGN,Amgen Inc,2017-10-10,California enacts law aimed at corralling high drug prices
AMGN,Amgen Inc,2017-10-09,China to accept out-of-country trial data to speed up drug approvals
AMGN,Amgen Inc,2017-10-07,Stocks to watch next week
AMGN,Amgen Inc,2013-07-02,U.S. futures higher ahead of data; Dow Jones up 0.31% 
AMGN,Amgen Inc,2013-07-01,U.S. stocks open higher  ISM data in focus; Dow Jones up 0.72% 
AMGN,Amgen Inc,2013-07-01,U.S. futures higher ahead of data; Dow Jones up 0.51% 
AMGN,Amgen Inc,2013-04-23,U.S. futures steady ahead of data  earnings; Dow Jones up 0.01% 
AMGN,Amgen Inc,2012-11-05,Wall Street climbs on election bullishness; Dow up 0.15%
AMGN,Amgen Inc,2012-11-05,U.S. stocks fall on election jitters; Dow Jones down 0.34%
AMGN,Amgen Inc,2012-11-05,U.S. futures steady  markets focus on U.S. elections; Dow Jones up 0.08%
AMGN,Amgen Inc,2012-10-23,Wall Street plunges on weak earnings  Spanish fears; Dow off 1.82%
AMGN,Amgen Inc,2012-10-23,U.S. stocks tumble on growth concerns; Dow Jones down 1.36%
AMGN,Amgen Inc,2012-04-25,U.S. futures higher  eyes on Fed statement; Dow Jones up 0.46%
AMGN,Amgen Inc,2017-11-29,Trump's Tax Promises Undercut by CEO Plans to Help Investors
AMGN,Amgen Inc,2017-11-17,Coherus down 13% on Amgen launch of single-dose cartridge version of Enbrel
AMGN,Amgen Inc,2017-11-14,Biotechs continue slide  XBI down 2%
AMGN,Amgen Inc,2017-11-07,U.S. investors target 'buyback stocks' in bet on Trump tax plan
AMGN,Amgen Inc,2017-11-02,CMS issues final list of therapies facing expiration of pass-through status for 2018
AMGN,Amgen Inc,2017-10-31,Japan's Kirin cashes out of Amgen drug joint venture
AMGN,Amgen Inc,2017-10-30,Avenue Therapeutics up 12% on start of late-stage study of pain med IV tramadol
AMGN,Amgen Inc,2017-10-26,Seattle Genetics Q3 revenues up 27%; earnings up 257%
AMGN,Amgen Inc,2017-10-26,Biotechs under pressure after Celgene revenue miss and guidance revision
AMGN,Amgen Inc,2017-10-25,Amgen quarterly profit tops expectations despite sales decline
AMGN,Amgen Inc,2018-01-24,Profit-taking weighs on biotechs and biopharmas
AMGN,Amgen Inc,2018-01-23,J&J takes $13.6 billion charge related to new U.S. tax law
AMGN,Amgen Inc,2018-01-17,High Hopes for Fourth-Quarter Earnings  
AMGN,Amgen Inc,2018-01-16,FDA launches new program to boost transparency of clinical data used to support approvals
AMGN,Amgen Inc,2018-01-09,U.S. pharma executives expect deals to pick up after tax overhaul
AMGN,Amgen Inc,2018-01-08,Start of JPM18 fails to buoy healthcare stocks
AMGN,Amgen Inc,2018-01-02,Drugmakers raise 2018 U.S. prices  stick to self-imposed limits
AMGN,Amgen Inc,2017-12-22,Amgen estimates its U.S. tax bill at over $6 billion as it repatriates cash
AMGN,Amgen Inc,2017-12-13,Bumper crop of new drugs fails to lift big pharma R&D returns
AMGN,Amgen Inc,2017-12-06,Biotech drug pricing should not get substantially worse next year - Mizuho
AMGN,Amgen Inc,2018-03-05,Share Buybacks Boom As Companies Invest Tax Savings  
AMGN,Amgen Inc,2018-02-23,Tenax to reverse split stock 1:20; shares down 13% premarket
AMGN,Amgen Inc,2018-02-12,Akebia and Otsuka tweak design of late-stage vadadustat studies  marketing approval in Japan may be 2021; shares down 2%
AMGN,Amgen Inc,2018-02-05,Spectrum Pharma's Rolontis on par with Neulasta in late-stage study; shares ahead 7% premarket
AMGN,Amgen Inc,2018-02-01,Amgen Q4 top line off 3%; non-GAAP EPS flat; shares down 5% after hours
AMGN,Amgen Inc,2018-01-31,Notable earnings after Thursday’s close
AMGN,Amgen Inc,2018-01-31,Big biopharma firms poised to end session in the red after Trump comments on high prices
AMGN,Amgen Inc,2018-01-31,North Korea threats spur U.S. search for new radiation therapies
AMGN,Amgen Inc,2018-01-29,Economic Calendar: Top Things to Watch 
AMGN,Amgen Inc,2018-01-26,Key events next week - healthcare
AMGN,Amgen Inc,2018-04-23,Amid drug price worries  earnings to test U.S. pharma  biotech shares
AMGN,Amgen Inc,2018-04-19,New Novartis CEO feels heat on U.S. generics business
AMGN,Amgen Inc,2018-04-04,Oryzon Genomics on go with mid-stage study of Alzheimer's candidate ORY-2001
AMGN,Amgen Inc,2018-03-28,FDA working on policies to boost biosimilars
AMGN,Amgen Inc,2018-03-28,Selloff continues in biotechs  XBI down 2%
AMGN,Amgen Inc,2018-03-26,Positive late-stage results for Biohaven's rimegepant fails to lift shares  down 29% premarket
AMGN,Amgen Inc,2018-03-25,Singapore pharma on recovery path after worst output in decades
AMGN,Amgen Inc,2018-03-09,Key events next week - healthcare (continued #4)
AMGN,Amgen Inc,2018-03-09,Key events next week - healthcare (continued #3)
AMGN,Amgen Inc,2018-03-06,Amgen to acquire ~$10B in stock in tender offer
AMGN,Amgen Inc,2018-06-01,Novartis readies anti-sexism message for migraine drug
AMGN,Amgen Inc,2018-05-18,Investors bullish on biotechs after Trump drug pricing speech
AMGN,Amgen Inc,2018-05-16,Biotechs perk up ahead of ASCO abstract drop
AMGN,Amgen Inc,2018-05-14,Oryzon Genomics commences mid-stage study of Alzheimer's candidate
AMGN,Amgen Inc,2018-05-11,Trump speech on drug prices light on specifics
AMGN,Amgen Inc,2018-05-11,Trump plan on drug prices to be announced this afternoon
AMGN,Amgen Inc,2018-04-26,Alexion Pharma Q1 revenues up 7%; non-GAAP EPS up 22%; raises revenue guidance
AMGN,Amgen Inc,2018-04-24,Express Scripts targets Amgen  Lilly migraine drugs in pricing shift
AMGN,Amgen Inc,2018-04-24,Top 5 Things to Know in the Market on Tuesday
AMGN,Amgen Inc,2018-04-24,Express Scripts targets new migraine drugs to change U.S. pricing dynamic
AMGN,Amgen Inc,2018-07-24,Citron's Left reiterates belief AbbVie shares will fall sharply
AMGN,Amgen Inc,2018-07-17,AbbVie out-licenses Humira patents to Mylan  biosimilar sales five years away in U.S.
AMGN,Amgen Inc,2018-07-16,CVS responds to Trump Administration's request for info on now to lower drug prices
AMGN,Amgen Inc,2018-07-11,Big Pharma in the red after Pfizer backs away from price hikes
AMGN,Amgen Inc,2018-07-10,Pricing transparency law in California having effect  drug makers nix planned increases
AMGN,Amgen Inc,2018-07-09,Biotechs give up gains after Trump tweet on prices
AMGN,Amgen Inc,2018-07-06,Alzheimer's players in the green on Biogen news
AMGN,Amgen Inc,2018-07-05,Drugmakers try evasion  tougher negotiations to fight new U.S. insurer tactic
AMGN,Amgen Inc,2018-06-11,Early-stage study of Advaxis' cancer candidate ADXS-NEO underway
AMGN,Amgen Inc,2018-06-11,Biotech's Soon-Shiong hiring bankers for Nant cancer drug IPO
AMGN,Amgen Inc,2018-10-11,Abbvie settles Humira patent disputes with Novartis unit
AMGN,Amgen Inc,2018-10-11,Amgen Falls 3%
AMGN,Amgen Inc,2018-10-03,Impatient patients turn to online 'buyers club' for new drugs
AMGN,Amgen Inc,2018-09-10,Amgen Rises 3.09%
AMGN,Amgen Inc,2018-08-23,Oklahoma first state to negotiate efficacy-based drug prices
AMGN,Amgen Inc,2018-08-07,Radius Health beats by $0.36  beats on revenue
AMGN,Amgen Inc,2018-08-02,German Stock Exchange approves delisting request of Precision Therapeutics
AMGN,Amgen Inc,2018-07-31,Amgen Rises 3.01% As Investors Eye Earnings
AMGN,Amgen Inc,2018-07-26,Amgen profit beats Street view  will not raise prices again in 2018
AMGN,Amgen Inc,2018-07-26,Top 5 Things To Know In The Market On Thursday
AMGN,Amgen Inc,2018-10-29,Notable earnings after Tuesday’s close
AMGN,Amgen Inc,2018-10-24,Amgen Falls 3%
AMGN,Amgen Inc,2018-10-23,BeyondSpring's Plinabulin shows positive effect in preventing chemo-induced neutropenia
AMGN,Amgen Inc,2018-10-23,Biotechs set for down gap at open
AMGN,Amgen Inc,2018-10-17,Stocks - Netflix Soars in Pre-market; IBM  Tilray  Canopy Growth Sink; Tesla Rises
AMGN,Amgen Inc,2018-10-17,Exclusive: Express Scripts covers Amgen  Lilly migraine therapies  excludes Teva drug
AMGN,Amgen Inc,2018-10-16,Amgen Rises 3%
AMGN,Amgen Inc,2018-10-16,Intra-Cellular Therapies appoints Mark Neumann as Executive VP  Chief Commercial Officer
AMGN,Amgen Inc,2018-10-16,Cytokinetics debuts two new pipeline candidates at R&D Day
AMGN,Amgen Inc,2018-10-15,FDA issues new guidance aimed at more efficient drug development
AMGN,Amgen Inc,2018-12-06,BeyondSpring's lead candidate on par with Amgen's Neulasta in late-stage study; shares ahead 3%
AMGN,Amgen Inc,2018-12-06,Spectrum Pharma's Rolontis on par with Amgen's Neulasta in late-stage breast cancer study
AMGN,Amgen Inc,2018-12-04,Amgen's BiTE candidate AMG 420 shows positive action in early-stage blood cancer study but AMG 330 lags
AMGN,Amgen Inc,2018-12-03,Amgen Falls 3%
AMGN,Amgen Inc,2018-11-28,Jefferies: AWS headed for $71B in revenue
AMGN,Amgen Inc,2018-11-16,Goldman bumps Novartis rating to Buy
AMGN,Amgen Inc,2018-11-07,Amgen Rises 3%
AMGN,Amgen Inc,2018-11-02,Amgen Falls 3%
AMGN,Amgen Inc,2018-10-31,Amgen Rises 3%
AMGN,Amgen Inc,2018-10-30,Amgen Earnings  Revenue beat in Q3
AMGN,Amgen Inc,2019-01-14,U.S. lawmaker launches investigation into pharma drug pricing
AMGN,Amgen Inc,2019-01-04,Amgen Rises 3%
AMGN,Amgen Inc,2019-01-03,Stocks - Apple Plunges in Premarket; Celgene  IZEA Soar; Starbucks  Amgen Drop
AMGN,Amgen Inc,2019-01-02,Teva  Amgen end dispute over generic Cinacalcet HCl tablets
AMGN,Amgen Inc,2019-01-02,Drug makers OK with price inclusion in TV ads if done fairly
AMGN,Amgen Inc,2018-12-26,Amgen Rises 3%
AMGN,Amgen Inc,2018-12-19,Exclusive: Big Pharma returning to U.S. price hikes in January after pause
AMGN,Amgen Inc,2018-12-13,"Senate Dems introduce bill to block ""excessive"" increases in drug prices"
AMGN,Amgen Inc,2018-12-11,Stocks - Alphabet  Wells Fargo  Ford  GM Gain in Premarket; Stitch Plunges
AMGN,Amgen Inc,2018-12-07,Amgen Falls 3%
AMGN,Amgen Inc,2019-01-30,Stocks - Apple  AMD  Boeing Surge in Premarket  AT&T  Amgen Drop
AMGN,Amgen Inc,2019-01-29,Amgen quarterly profit tops Street view  2019 forecast falls short
AMGN,Amgen Inc,2019-01-29,Amgen Earnings  Revenue beat in Q4
AMGN,Amgen Inc,2019-01-28,Caterpillar and Nvidia warnings send Wall Street tumbling
AMGN,Amgen Inc,2019-01-28,Amgen Falls 3%
AMGN,Amgen Inc,2019-01-25,Exclusive: CVS to cover migraine drugs from Teva  Lilly; excludes Amgen
AMGN,Amgen Inc,2019-01-23,Jefferies bearish on biotechs  sees 6% near-term downside
AMGN,Amgen Inc,2019-01-16,Hospitals squeezed by high drug costs
AMGN,Amgen Inc,2019-01-15,FDA to beef up cell and gene therapy staff
AMGN,Amgen Inc,2019-01-30,Amgen Falls 5%
AMGN,Amgen Inc,2019-01-30,Amgen Falls 5%
AMGN,Amgen Inc,2019-03-07,Amgen declares $1.45 dividend
AMGN,Amgen Inc,2019-03-06,Amgen Falls 3%
AMGN,Amgen Inc,2019-03-06,Biotech Companies Slump Midday With FDA Chief Set to Leave
AMGN,Amgen Inc,2019-03-05,FDA chief tough on e-cigs steps down in surprise resignation
AMGN,Amgen Inc,2019-02-12,Boehringer Ingelheim teams up with IBM to explore use of blockchain in clinical trials
AMGN,Amgen Inc,2019-02-11,Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
AMGN,Amgen Inc,2019-02-07,Amgen Falls 3%
AMGN,Amgen Inc,2019-02-06,Exclusive: Facing crackdown in Canada  drugmakers offered billions in price cuts
AMGN,Amgen Inc,2019-01-30,Amgen on hunt for acquisitions to drive growth
AMGN,Amgen Inc,2019-04-09,FDA OKs Amgen's osteoporosis med Evenity
AMGN,Amgen Inc,2019-04-09,Why Amgen Can Deliver Medical and Financial Miracles
AMGN,Amgen Inc,2019-04-07,Why Amgen's Giving Novartis a Headache
AMGN,Amgen Inc,2019-04-05,Lawsuit over migraine deal could be good for Amgen  analysts say
AMGN,Amgen Inc,2019-04-04,Brainstorm Health: Brainstorm Health  Alexa for Health Care  Novartis Sues Amgen
AMGN,Amgen Inc,2019-04-04,Novartis sues Amgen over Aimovig
AMGN,Amgen Inc,2019-03-17,Better Buy: Amgen vs. Gilead Sciences
AMGN,Amgen Inc,2019-03-15,Amgen to launch large-scale study to assess long-term outcome for Repatha
AMGN,Amgen Inc,2019-03-15,BMO likes Amgen and Gilead in premarket analyst action
AMGN,Amgen Inc,2019-03-10,Better Buy: Amgen vs. Biogen
